BNS, 21.04.2026.
While medications are currently produced mainly in bulk, 3D printing could bring drug manufacturing closer to the patient in the future. A recent study led by Kristiine Roostar, a junior researcher in pharmaceutical technology at the University of Tartu, takes a step toward this goal by highlighting possibilities for more precise printing of medications.
While medications are currently produced mainly in bulk, 3D printing could bring drug manufacturing closer to the patient in the future. A recent study led by Kristiine Roostar, a junior researcher in pharmaceutical technology at the University of Tartu, takes a step toward this goal by highlighting possibilities for more precise printing of medications.
Pieteikšanās reģistrētiem LPMA biedriem.